TATA HEALTH (01255) announced that Mr. Zhang Mingqi has been reassigned from a non-executive director to an executive director and appointed as the company's Chief Executive Officer, effective from October 21, 2025. Mr. Xu Jianda will be appointed as the Chief Financial Officer of the company, also effective from October 21, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.